Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nora Isberner

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Clinical Biochemistry|April 28, 2022
Comparison of a newly developed high performance liquid chromatography method with diode array detection to a liquid chromatography tandem mass spectrometry method for the quantification of cabozantinib, dabrafenib, nilotinib and osimertinib in human serum - Application to therapeutic drug monitoringFatemeh Aghai-Trommeschlaeger, Sebastian Zimmermann, Anja Gesierich, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 5, 2022
Volumetric absorptive microsampling (VAMS) for the quantification of ten kinase inhibitors and determination of their in vitro VAMS-to-plasma ratioSebastian Zimmermann, Fatemeh Aghai, Bastian Schilling, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 25, 2023
Clinical validation and assessment of feasibility of volumetric absorptive microsampling (VAMS) for monitoring of nilotinib, cabozantinib, dabrafenib, trametinib, and ruxolitinibSebastian Zimmermann, Fatemeh Aghai-Trommeschlaeger, Sabrina Kraus, et al.
Journal of Clinical Medicine|September 10, 2021
Specific Risk Factors for Fatal Outcome in Critically Ill COVID-19 Patients: Results from a European Multicenter StudyDavid Meintrup, Stefan Borgmann, Karlheinz Seidl, et al.
Blood Advances|January 29, 2026
Significant burden of low-grade infections in patients treated with T-cell-engaging therapies for Multiple MyelomaJulia Mersi, Lara Burow, Xiang Zhou, et al.
Frontiers in Artificial Intelligence|September 20, 2021
Reliable and Interpretable Mortality Prediction With Strong Foresight in COVID-19 Patients: An International Study From China and GermanyTao Bai, Xue Zhu, Xiang Zhou, et al.
Infection|April 14, 2021
Clinical course and predictive risk factors for fatal outcome of SARS-CoV-2 infection in patients with chronic kidney diseaseLisa Pilgram, Lukas Eberwein, Kai Wille, et al.
United European Gastroenterology Journal|April 28, 2022
COVID-19 mortality in cirrhosis is determined by cirrhosis-associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registryJonathan F Brozat, Frank Hanses, Martina Haelberger, et al.
Plos One|July 29, 2022
Hospitalized patients dying with SARS-CoV-2 infection-An analysis of patient characteristics and management in ICU and general ward of the LEOSS registryClaudia Raichle, Stefan Borgmann, Claudia Bausewein, et al.
Scientific Reports|November 9, 2022
Convalescent plasma treatment for SARS-CoV-2 infected high-risk patients: a matched pair analysis to the LEOSS cohortNoemi F Freise, Smaranda Gliga, Johannes Fischer, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical Biochemistry|April 28, 2022
Comparison of a newly developed high performance liquid chromatography method with diode array detection to a liquid chromatography tandem mass spectrometry method for the quantification of cabozantinib, dabrafenib, nilotinib and osimertinib in human serum - Application to therapeutic drug monitoringFatemeh Aghai-Trommeschlaeger, Sebastian Zimmermann, Anja Gesierich, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 5, 2022
Volumetric absorptive microsampling (VAMS) for the quantification of ten kinase inhibitors and determination of their in vitro VAMS-to-plasma ratioSebastian Zimmermann, Fatemeh Aghai, Bastian Schilling, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 25, 2023
Clinical validation and assessment of feasibility of volumetric absorptive microsampling (VAMS) for monitoring of nilotinib, cabozantinib, dabrafenib, trametinib, and ruxolitinibSebastian Zimmermann, Fatemeh Aghai-Trommeschlaeger, Sabrina Kraus, et al.
Journal of Clinical Medicine|September 10, 2021
Specific Risk Factors for Fatal Outcome in Critically Ill COVID-19 Patients: Results from a European Multicenter StudyDavid Meintrup, Stefan Borgmann, Karlheinz Seidl, et al.
Blood Advances|January 29, 2026
Significant burden of low-grade infections in patients treated with T-cell-engaging therapies for Multiple MyelomaJulia Mersi, Lara Burow, Xiang Zhou, et al.
Frontiers in Artificial Intelligence|September 20, 2021
Reliable and Interpretable Mortality Prediction With Strong Foresight in COVID-19 Patients: An International Study From China and GermanyTao Bai, Xue Zhu, Xiang Zhou, et al.
Infection|April 14, 2021
Clinical course and predictive risk factors for fatal outcome of SARS-CoV-2 infection in patients with chronic kidney diseaseLisa Pilgram, Lukas Eberwein, Kai Wille, et al.
United European Gastroenterology Journal|April 28, 2022
COVID-19 mortality in cirrhosis is determined by cirrhosis-associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registryJonathan F Brozat, Frank Hanses, Martina Haelberger, et al.
Plos One|July 29, 2022
Hospitalized patients dying with SARS-CoV-2 infection-An analysis of patient characteristics and management in ICU and general ward of the LEOSS registryClaudia Raichle, Stefan Borgmann, Claudia Bausewein, et al.
Scientific Reports|November 9, 2022
Convalescent plasma treatment for SARS-CoV-2 infected high-risk patients: a matched pair analysis to the LEOSS cohortNoemi F Freise, Smaranda Gliga, Johannes Fischer, et al.
Pageof 2